Special Issue "Mesenchymal Stem/Progenitor Cells and Their Derivates in Tissue Regeneration - Part II"
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 8515
Interests: mesenchymal stem cells (MSCs); MSCs secretome; microvesicles (MVs); MSCs and bioactive factors; regenerative medicine; cellular therapy; muscular dystrophy; wound healing
Special Issues, Collections and Topics in MDPI journals
The first Special Issue “Mesenchymal Stem/Progenitor Cells and Their Derivates in Tissue Regeneration” has been recognized by many scientific groups and was a successful endeavor. This encouraged us to continue this Special Issue with a second part devoted to research concerning mesenchymal stem cell application in regenerative medicine.
Mesenchymal stem/progenitor cells (MSCs) reside in many human tissues and organs and play important roles in tissue regeneration and tissue homeostasis. These cells can be isolated from different tissues in the adult human body, expanded in vitro and applied for the regeneration of tissues and organs damaged by age, disease or extensive injury. Cells bearing MSC characteristics differ in the facets of proliferation and differentiation, which results in their diverse biological potential and applications in tissue regeneration. Experimental studies have shown that not only MSCs, but also their derivates—such as a conditioned medium containing a variety of bioactive factors or extracellular vesicles (EVs) (microvesicles and exosomes) carrying various cytoplasmic components, including lipids, DNA fragments and RNA (including mRNA and microRNA)—contribute to tissue recovery and angiogenesis and modify the inflammatory microenvironment in a paracrine and endocrine manner. This Special Issue will present state-of-the-art studies concerning the therapeutic effects of various stem/progenitor cells and/or their derivates in the context of tissue and organ regeneration. The potential topics to be covered include (1) bioactive factors released by mesenchymal stem/progenitor cells for cell-free therapy in tissue regeneration, (2) extracellular vesicles from parental mesenchymal stem/progenitor cells for cell-free therapy in tissue regeneration and (3) the proangiogenic properties of bioactive factors and/or extracellular vesicles released by MSCs.
Prof. Dr. Aleksandra Klimczak
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- mesenchymal stem cells
- mesenchymal stem/progenitor cells
- MSC secretome
- bioactive factors released by MSCs
- MSC extracellular vesicles (EVs)
- cell-free therapy
- tissue regeneration
- MSCs secretome and angiogenesis